Health care stocks declined Friday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each decreasing about 0.4%.
The iShares Biotechnology ETF (IBB) retreated 1.2%.
In corporate news, Apellis Pharmaceuticals (APLS) shares were falling 3%. The company has had a difficult Q1 as charitable foundation funding gaps and weaker-than-expected Syfovre sales weigh on the outlook, BofA Securities said in a report. BofA downgraded the stock to neutral from buy.
Iovance Biotherapeutics (IOVA) shares tumbled 46% after it lowered its 2025 product revenue guidance. Its Q1 results also missed estimates.
MeiraGTx (MGTX) shares added 1.0% after its investigational gene therapy, AAV-GAD, received regenerative medicine advanced therapy designation from the US Food and Drug Administration for the treatment of Parkinson's disease.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.